Ben Barron‐Millar, Laura Ogle, George Mells, Steven Flack, Jonathan Badrock, Richard Sandford, John Kirby, Jeremy Palmer, Laura Jopson, John Brain, Graham R. Smith, Steve Rushton, Vinod S. Hegade, Rebecca Jones, Simon Rushbrook, Douglas Thorburn, Steve Ryder, Gideon Hirschfield, UK‐PBC Research Consortium, Jessica K. Dyson, David E.J. Jones – 14 June 2021
Yuan‑Fei Shi, Wan‑Zhuo Xie – 14 June 2021
Averill Guo, Sydney Pomenti, Julia Wattacheril – 14 June 2021
Averill Guo, Sydney Pomenti, Julia Wattacheril – 14 June 2021
Yong Lv, Guohong Han – 14 June 2021
Nikhilesh R. Mazumder, Dinee Simpson, Kofi Atiemo, Kathryn Jackson, Lihui Zhao, Amna Daud, Abel Kho, Lauren G. Gabra, Juan C. Caicedo, Josh Levitsky, Daniela P. Ladner – 14 June 2021
Léa Duhaut, Mélanie Eyries, Maïté Lewin, Oriana Ciacio, Ilias Kounis, Daniel Cherqui, Teresa Antonini, Jean‐Charles Duclos‐Vallée, Cyrille Feray, Didier Samuel, Catherine Guettier, Audrey Coilly – 14 June 2021
Jerome C. Edelson, Don C. Rockey – 13 June 2021
Yang Shen, Francesca Cingolani, Shoaib Ahmad Malik, Jing Wen, Yunshan Liu, Mark J. Czaja – 11 June 2021
Nabeel A. Wahid, Jihui Lee, Alyson Kaplan, Brett E. Fortune, Monika M. Safford, Robert S. Brown, Russell Rosenblatt – 11 June 2021 – The Affordable Care Act expanded Medicaid around the same time that direct‐acting antivirals became widely available for the treatment of hepatitis C virus (HCV). However, there is significant variation in Medicaid HCV treatment eligibility criteria between states. We explored the combined effects of Medicaid expansion and leniency of HCV coverage under Medicaid on liver outcomes.